Functional studies of candidate genes contributing to type 1 diabetes in the NOD mouse

Keywords

Nod, Type 1 diabetes, NOD mice, Gene, Diabetes mellitus

References

• Abnormal T cell development in CD3‐zeta‐/‐ mutant mice and identification of a novel T cell population in the intestine.C.P. Liu, R. Ueda, Jingjing She — 1993
• Androgen treatment prevents diabetes in nonobese diabetic miceLauren Hall‐Lew — 1992
• Steroid production in the thymus: implications for thymocyte selectionM. Riad Manaa, George E. Overturf — 1994
• Genetic analysis of immune dysfunction in non‐obese diabetic (NOD) mice: Mapping of a susceptibility locus close to the Bcl‐2 gene correlates with increased resistance of NOD T cells to apoptosis inductionLibby Doggett — 1994
• Major Histocompatibility Complex Class I-Deficient NOD-B2mnull Mice are Diabetes and Insulitis ResistantKaren Banks — 1994
• Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain.J. Quintana Fernández — 1998
• Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2.Florence Padovani — 2000
• Development and selection of T cells: facts and puzzles.Paweł Kisielow, Harald von Boehmer — 1995
• T cell development in mice lacking the CD3‐zeta/eta gene.Marie Malissen, A. Gillet, Bénédita Rocha — 1993
• Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells.Thomas Mandrup‐Poulsen, Steffen Helqvist, Lise Wogensen — 1990
• Assessing the role of HLA-linked and unlinked determinants of disease.Neil Risch — 1987
• The mucosal milieu creates tolerogenic dendritic cells and TR1 and TH3 regulatory cellsHoward L. Weiner — 2001
• Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase IβJens Schlossmann, Aldo Ammendola, Keith Ashman — 2000
• The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3Craig L. Bennett, Jacinda R. Christie, Fred Ramsdell — 2001
• Checkpoint blockade in cancer immunotherapy.Alan J. Korman, Karl S. Peggs, James P. Allison — 2007
• The B7–CD28 superfamilyArlene H. Sharpe, Gordon J. Freeman — 2002
• Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus.M A Berman, Christy Sandborg, Z Wang — 1996
• Two Autoimmune Diabetes Loci Influencing T Cell Apoptosis Control Susceptibility to Experimental Autoimmune Myocarditis1Mehmet Güler, Davinna L. Ligons, Yan Wang — 2005
• Control of autoimmunity by naturally arising regulatory CD4+ T cells.Shohei Hori, Takeshi Takahashi, Shimon Sakaguchi — 2003
• Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous.Martin F. Bachmann, Gabriele Köhler, Barbara Ecabert — 1999

Cited by

No citing papers recorded for this paper.

Related papers

• Molecular genetics of diabetes mellitus.Timothy J. Aitman, John A. Todd — 1995
• Mouse models and the genetics of diabetes: is there evidence for genetic overlap between type 1 and type 2 diabetes?Edward H. Leiter, Chul‐Ho Lee — 2005
• [Heterogeneity of type 1 diabetes mellitus].Sérgio Atala Dib — 2008
• Genetic control of diabetes progression.Antonio González, Jonathan D. Katz, Marie‐Geneviève Mattéi — 1997
• Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities.Sunil Kumar Kota, Lalit Kumar Meher, Sruti Jammula — 2012
• Type 2 diabetes: genetic advance and aetiology.Mustafa Abdo Saif Dehwah, Zhang Shuang, Wang Zhen Hua — 2009
• Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes.Yisheng Yang, Lawrence Chan — 2016
• New autoimmune genes and the pathogenesis of type 1 diabetesLars Hornum, Helle Markholst — 2004
• The genetic basis for type 1 diabetes.K. L. Mehers, Kathleen M. Gillespie — 2008
• Diabetes-Obesity Syndromes in MiceDouglas L. Coleman — 1982